Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept Study
Sponsor: COMPASS Pathways
A PHASE2 clinical study on Anorexia Nervosa, this trial is completed. The trial is conducted by COMPASS Pathways and has accumulated 10 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Jan 2025 — Present [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Oct 2024 — Jan 2025 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — Oct 2024 [monthly]
Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE2
-
Jan 2024 — Jul 2024 [monthly]
Recruiting PHASE2
▶ Show 5 earlier versions
-
Aug 2023 — Jan 2024 [monthly]
Recruiting PHASE2
-
Jun 2023 — Aug 2023 [monthly]
Recruiting PHASE2
-
Mar 2023 — Jun 2023 [monthly]
Recruiting PHASE2
-
Nov 2022 — Mar 2023 [monthly]
Recruiting PHASE2
-
Sep 2022 — Nov 2022 [monthly]
Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- COMPASS Pathways
For direct contact, visit the study record on ClinicalTrials.gov .